Painkillers can improve the quality of life
significantly for people suffering with chronic pain. Various medications are
available for pain, but prescription opioid medications can have terrible side
effects and addictive qualities, as explained by Dr. McGhee. Looking at the
addictive side of opioid pain medication, this can cause people who are in pain
to be denied relief because of doctors not wanting to supply people who are
addicted or at risk of becoming addicted.
The
article “The Pain Medication Conundrum” exhibits the debate that doctors have
over whether or not they should prescribe medication to a patient, especially
if he or she has a history of drug abuse. Dr. Ofri goes through an experience
he had highlighting the issue there is with prescription pain medication
because, although it greatly reduces the pain in people, doctors are reluctant
to offer it due to overdose and adverse side effects.
Dr.
Ofri tells about how a patient he had been seeing for six months with multiple
health issues asks for strong medication because the pain clinic the patient
was receiving medication from closed down. Along with this, his patient had a
history of heroin abuse, and was unsure if he could trust the patient’s story.
As well as difficulty trusting patients, doctors also have the issue of undertreating
or overprescribing medication and are stuck in this predicament of
undertreatment of pain or possibly contributing to an overdose.
While
these issues can be addressed by having different protocol for prescribing pain
medication, these issues would significantly lessen if the side effects and
addictiveness of opioid pain medication is less intense. This is what Dr.
McGhee has been working on, and the research is important for these situations
where doctors are in a situation of wanting to relieve pain but are reluctant
because of the risk of the patient overdosing.
References:
McGhee*, D.S., & Daniele, C.A., & Umana, I.C. (2013). Neuronal nicotinic receptors as analgesic targets: it's a winding road. Elsevier. 8. 1208-1214. DOI: https://doi.org/10.1016/j.bcp.2013.08.001
Ofri, D. (2015). The pain medication conundrum. The New York Times Company. Retrieved from https://www.nytimes.com/2015/08/13/opinion/the-pain-medication-conundrum.html?_r=0
References:
McGhee*, D.S., & Daniele, C.A., & Umana, I.C. (2013). Neuronal nicotinic receptors as analgesic targets: it's a winding road. Elsevier. 8. 1208-1214. DOI: https://doi.org/10.1016/j.bcp.2013.08.001
Ofri, D. (2015). The pain medication conundrum. The New York Times Company. Retrieved from https://www.nytimes.com/2015/08/13/opinion/the-pain-medication-conundrum.html?_r=0
No comments:
Post a Comment